Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bruker Introduces Novel AVANCE III HD NMR Spectrometer

Published: Monday, July 09, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
The new AVANCE III HD is the Ultimate NMR platform for life science and materials research, as well as a robust, automated and easy-to-use analysis system for pharma/biotech, chemistry, metabolomics, nutritional science and molecular diagnostics research.

At the Experimental Nuclear Magnetic Resonance Conference (ENC) 2012, Bruker has introduced the novel AVANCE III HD NMR spectrometer.

Thanks to its new digital RF synthesizer, further enhanced receiver electronics, redesigned preamplifiers, extended Digital Lock™ and SmartVT™ capabilities, Bruker now has further enhanced the most sensitive and most accurate, highest performance NMR spectrometer on the market, bringing High Definition (HD) technology to AVANCE NMR users.

The AVANCE III HD spectrometer benefits from a next-generation RF synthesizer with significantly increased digital integration, incorporating a lower phase noise local oscillator (LO) and a high speed DA converter running at 960 MHz.

This enables extended digital RF power settings up to NMR frequencies of 1.2 GHz.

Together with the new high dynamic range and high sensitivity preamplifiers, the AVANCE III HD demonstrates improved spectral purity, fully exploits the increased sensitivity of the latest NMR probe technology and enables sensitivity improvements of up to 30% for the most demanding applications.

These include experiments on bio-molecular samples in buffers or detergents, metabolic beverage analysis for food safety and quality, and trace analysis such as impurity detection in drugs and other pharmaceutical compounds.

With the new AVANCE III HD preamplifiers and the new GaAs FET-based broad-band technology, solid-state NMR applications in particular will directly benefit from up to a 20% increase in sensitivity on 13C and other X nuclei.

A novel impedance matching technology ensures solids spectra with excellent symmetry, and the active, fast high power transmit/receive switch guarantees maximum linearity even at the lowest power levels.

The AVANCE III HD now provides solid-state NMR researchers with access to fully broad-banded capacities and easier daily routine operation without the need for manual interaction.

A touch-screen display enables high-definition tuning and matching of the system and monitoring of the probe status.

With the revolutionary NMR Thermometer™ for the first time, the measurement of the exact internal sample temperature by NMR itself is possible.

This is achieved fully automatically through the measurement of the chemical shift difference between two deuterium resonances, rather than relying on inaccurate external thermocouples.

While one deuterium signal is used for field stabilization, the chemical shift difference to the second signal is used together with the SmartVT™ to both measure and maintain a constant temperature within the sample.

Based on the measurement of the actual sample temperature, the NMR Thermometer™ now offers the possibility of up to 50% times faster on-line regulation of sample temperature, more efficient compensation for heating effects caused by RF pulse sequences, or by sample spinning in MAS experiments.

This results in an immediate improvement in the accuracy and precision of the acquired signal frequencies by up to a factor 5, delivering improved accuracy in the assignment of resonances, especially in solid-state, and 2D/3D/4D protein and biomolecular NMR applications.

"With our unsurpassed commitment to innovation and to bringing the latest technology to the field of NMR, the new AVANCE III HD spectrometer once again offers enabling R&D innovations and performance breakthroughs from our R&D centers and key customer collaborations to all NMR customers," said Dr. Frank Laukien, Bruker's President and CEO.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Novel Approach for Inborn Errors of Metabolism Screening by NMR
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogeneous metabolites and 45 metabolites associated with inborn errors of metabolism.
Wednesday, September 04, 2013
Scientific News
How Different People Respond To Aspirin
Study findings could be used to help identify those who would benefit most from aspirin use.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
‘Big Data’ Drills Down Into Metabolic Details
Rice University bioengineers introduce efficient way to analyze, compare tissue-specific pathways.
New Approach to Curbing Cancer Cell Growth
Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!